We are live on ! Find out more
TRAW icon

Traws Pharma

17 hedge funds and large institutions have $38.2M invested in Traws Pharma in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

23% less funds holding

Funds holding: 2217 (-5)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

62% less capital invested

Capital invested by funds: $102M → $38.2M (-$63.3M)

Holders
17
Holders Change
-5
Holders Change %
-22.73%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
1
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CS
26
Credit Suisse
Switzerland
$172K
MWNA
27
Marshall Wace North America
New York
$166K
Citadel Advisors
28
Citadel Advisors
Florida
$161K
Citigroup
29
Citigroup
New York
$161K
Charles Schwab
30
Charles Schwab
California
$148K
VKH
31
Virtu KCG Holdings
New York
$143K
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$123K
Invesco
33
Invesco
Georgia
$115K
KPCM
34
Kings Point Capital Management
New York
$63K
TA
35
Teachers Advisors
New York
$63K
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$61K
NFA
37
Nationwide Fund Advisors
Ohio
$51K
AIG
38
American International Group
New York
$45.3K
BA
39
BlackRock Advisors
Delaware
$34K
Bank of America
40
Bank of America
North Carolina
$30K
SO
41
STRS Ohio
Ohio
$28K
U
42
UBS
Switzerland
$25K
TRCT
43
Tower Research Capital (TRC)
New York
$18K
GC
44
Globeflex Capital
California
$2K
Barclays
45
Barclays
United Kingdom
$1K
Canada Life
46
Canada Life
Manitoba, Canada
$1K
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$448
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$12
DM
49
Deerfield Management
New York
-$25.6M -17 Closed
Lord, Abbett & Co
50
Lord, Abbett & Co
New Jersey
-$5.19M -3 Closed

TRAW Hedge Fund Activity: Q4 2013 in Review

17 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q4 2013, worth a combined $38.2M — down 62% from $102M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TRAW and 5 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 5 added.

The largest buyer was Fidelity Investments, adding an estimated $10.4M. The largest seller was Deerfield Management, exiting entirely with an estimated $25.6M sold.

  • 17 institutional investors held Traws Pharma (TRAW) as of Q4 2013, down from 22 in Q3 2013.
  • Funds reported $38.2M of Traws Pharma stock for Q4 2013, down 62% quarter-over-quarter.
  • 5 funds opened new Traws Pharma positions in Q4 2013 and 10 closed out, a net change of -5 holders.
  • The largest Traws Pharma buyer in Q4 2013 was Fidelity Investments, an estimated $10.4M added.
  • The largest Traws Pharma seller in Q4 2013 was Deerfield Management, an estimated $25.6M sold.

Based on aggregated 13F filings for Q4 2013.